News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Clinical, In the Media, Research
New Approach to Designing Drugs Supercharges Cancer Medication
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked. The drugs are precise, but can attack only one kind of target […]
Clinical, In the Media, Research
The Future of Brain Tumor Care is Being Built Now — at Siteman Cancer Center
WashU Medicine experts at Siteman’s Brain Tumor Center are accelerating the science that will create a new standard and new survivorship for brain tumor care For years, progress against glioblastoma has been measured in small steps with only slight improvements in survival. Now, at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, bold research and remarkable advances against this deadliest form of […]
In the Media, Research, Staff/Faculty Update
Cynthia Ma Receives Susan G. Komen Leadership Grant
Cynthia X. Ma, MD, PhD, a renowned WashU Medicine physician-scientist at Siteman Cancer Center, has received a Leadership Grant from Susan G. Komen to advance breast cancer research focused on endocrine resistance, a major challenge in treatment for hormone receptor-positive breast cancer. A medical oncologist, Ma treats patients with this and other types of breast cancer at Siteman Cancer […]
In the Media, Research
Faster Aging in Younger Generations Linked To Rise in Early-Onset Cancer
Immune system aging linked to earlier lung cancer; fat tissue aging linked to earlier colorectal cancer Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation. But as cancer rates in younger adults rise, with each […]
In the Media, Research
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer
WashU researchers at Siteman Cancer Center combine optical coherence tomography and machine learning for rapid, accurate test Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing up to 3% annually. Diagnosis requires an often painful and invasive biopsy that carries a risk of […]
In the Media, Research
Targeting Tumor Metabolism to Fight Cancer
Cancer cells are ravenous eaters. Gary Patti is trying to turn their hunger against them. By their nature, cancer cells have different nutritional needs than healthy cells. “Cancer cells have a distinct metabolism,” said Gary J. Patti, PhD, the Michael and Tana Powell Professor of Chemistry and a professor of genetics and medicine at WashU Medicine and a […]
In the Media, Research
Siteman Cancer Center Shares the Latest in Medical Oncology, Screening Innovation and Translational Science at ASCO
WashU Medicine physician-scientists and others affiliated with Siteman will share findings from multi-institutional studies they lead and will present on health equity, mentorship and more at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. At the 2026 annual meeting of the American Society of Clinical Oncology (ASCO), WashU Medicine scientists and physician-researchers at Siteman Cancer Center will […]
In the Media, Research
Gene-Edited Stem Cell Transplant Shows Promise for Aggressive Blood Cancers
Strategy seeks to expand immunotherapies for leukemia, other malignancies For highly aggressive types of blood cancer, stem cell transplantation is often the only potentially curative therapy, yet even after a transplant, these cancers often return. Now, a clinical trial, led by researchers at Washington University School of Medicine in St. Louis, shows that a stem cell […]
In the Media, Research
Personalized Vaccine Shows Promise Against Aggressive Brain Cancer
Participants in early clinical trial had increased immune response, slowed tumor progression A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appears to increase recurrence-free survival in a subset of patients after surgery, […]
Patient & Donor Stories, Research
Donor provides gift for blood cancer research
Anita Palmer Corbin learned to meet challenges head-on when she was diagnosed with Type 1 diabetes at age 10 in 1964. Her mother first noticed the symptoms, and after blood tests confirmed a problem, she was admitted to Cardinal Glennon Children’s Hospital in St. Louis, located one hour north of her home in Ste. Genevieve, […]